Journal of International Obstetrics and Gynecology ›› 2024, Vol. 51 ›› Issue (6): 707-711.doi: 10.12280/gjfckx.20240854

• Gynecological Disease & Related Research: Review • Previous Articles     Next Articles

Progress in Evaluating Embryotoxicity of Compounds Based on Human Embryonic Stem Cell Model in Vitro

SUN Lu, CHEN Ran-ran, SONG Dian-rong()   

  1. Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China (SUN Lu); Department of Gynecology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300150, China (CHEN Ran-ran, SONG Dian-rong)
  • Received:2024-09-19 Published:2024-12-15 Online:2024-12-16
  • Contact: SONG Dian-rong, E-mail: songdr58@126.com

Abstract:

Embryonic stem cell test (EST) was widely used in evaluation of embryotoxicity or developmental toxicity of compounds in the fields of drugs, chemicals, and environmental safety. In recent years. Compared to the traditional reproductive toxicity tests, EST has the advantages of short cycletime, high throughput and low loss, in order to further improve the applicability and safety assessment of EST to various drugs and to avoid species differences, researchers used human embryonic stem cell (hESC) instead of the original mouse embryonic stem cell (mESC), and the researches which utilized hESC to evaluate embryotoxicity or developmental toxicity have been became more diversified and in-depth, such as the development of different evaluation models of differentiation types (myocardial cell, nerve cell and osteoblast etc.) or the construction of three-dimensional (3D) models which were closer to real living condition of embryo (embryoid bodys and organoid), these studies provided a new direction for establishing a more accurate and efficient model for the evaluation of embryotoxicity.

Key words: Human embryonic stem cells, Embryo, mammalian, Models, theoretical, Cells, cultured, In vitro techniques, Embryotoxicity